Melanoma Clinical Trial
Psychoeducation for Uveal Melanoma
Summary
This clinical trial evaluates a video-based psychoeducational intervention for patients with uveal melanoma. Uveal melanoma (UM) is a rare intraocular cancer. UM patients face an uncertain course of survivorship in terms of their visual acuity, treatment-related side effects, and risk for eventual metastasis of the cancer. Learning about patients' thoughts and reactions to informational resources may better support patients during ocular melanoma survivorship.
Full Description
PRIMARY OBJECTIVE:
I. To assess the efficacy of the psychoeducation intervention (compared to the control condition) in modifying illness perceptions of disease control, chronicity, and coherence (i.e., to become less threatening) over the course of the follow-up period.
SECONDARY OBJECTIVE:
I. To assess the efficacy of the psychoeducation intervention (compared to the control condition) in reducing the degree of participant's depressive and anxiety symptoms over the course of the follow-up period.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants watch two fifteen-minute educational videos and receive a mental health resource information sheet on study.
ARM II: Patients receive enhanced treatment as usual and receive a mental health resource information sheet on study.
Eligibility Criteria
Inclusion Criteria:
Adults (age 18 years and older at visit 1)
History of uveal melanoma as documented in their University of California, Los Angeles (UCLA) medical record
Receipt of uveal melanoma treatment and/or ongoing follow-up care at the UCLA Jules Stein Eye Institute, as documented in their UCLA medical record
Ability to read, write, and converse in English
Access to the internet via a computer or cell phone
Access to a personal email address
Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study
Exclusion Criteria:
-
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?